Kidney transplant patients test weekly Self-Injections to replace monthly clinic visits

This study is testing whether kidney transplant patients who have been stable on monthly IV infusions for over two years can safely switch to weekly self-administered injections. Researchers want to see if the new injection method maintains kidney function as well as the current IV treatment. The trial involves 87 patients who will be randomly assigned to either continue their current treatment or switch to the injections, with their kidney function monitored for two years.